197 related articles for article (PubMed ID: 25925926)
1. Refractory celiac disease: epidemiology and clinical manifestations.
Malamut G; Cellier C
Dig Dis; 2015; 33(2):221-226. PubMed ID: 25925926
[TBL] [Abstract][Full Text] [Related]
2. Refractory celiac disease.
Malamut G; Cellier C
Expert Rev Gastroenterol Hepatol; 2014 Mar; 8(3):323-8. PubMed ID: 24502536
[TBL] [Abstract][Full Text] [Related]
3. Refractory coeliac disease.
Malamut G; Cellier C
Curr Opin Oncol; 2013 Sep; 25(5):445-51. PubMed ID: 23942290
[TBL] [Abstract][Full Text] [Related]
4. Refractory Celiac Disease.
Malamut G; Cellier C
Gastroenterol Clin North Am; 2019 Mar; 48(1):137-144. PubMed ID: 30711206
[TBL] [Abstract][Full Text] [Related]
5. Refractory celiac disease.
Malamut G; Murray JA; Cellier C
Gastrointest Endosc Clin N Am; 2012 Oct; 22(4):759-72. PubMed ID: 23083992
[TBL] [Abstract][Full Text] [Related]
6. Monitoring nonresponsive patients who have celiac disease.
Krauss N; Schuppan D
Gastrointest Endosc Clin N Am; 2006 Apr; 16(2):317-27. PubMed ID: 16644460
[TBL] [Abstract][Full Text] [Related]
7. Refractory celiac disease: from bench to bedside.
Malamut G; Meresse B; Cellier C; Cerf-Bensussan N
Semin Immunopathol; 2012 Jul; 34(4):601-13. PubMed ID: 22810901
[TBL] [Abstract][Full Text] [Related]
8. Complications of coeliac disease.
Malamut G; Cellier C
Best Pract Res Clin Gastroenterol; 2015 Jun; 29(3):451-8. PubMed ID: 26060109
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic yield of capsule endoscopy in refractory celiac disease.
Barret M; Malamut G; Rahmi G; Samaha E; Edery J; Verkarre V; Macintyre E; Lenain E; Chatellier G; Cerf-Bensussan N; Cellier C
Am J Gastroenterol; 2012 Oct; 107(10):1546-53. PubMed ID: 22964554
[TBL] [Abstract][Full Text] [Related]
10. Update on the diagnosis and management of refractory coeliac disease.
Nijeboer P; van Wanrooij RL; Tack GJ; Mulder CJ; Bouma G
Gastroenterol Res Pract; 2013; 2013():518483. PubMed ID: 23762036
[TBL] [Abstract][Full Text] [Related]
11. A locus at 7p14.3 predisposes to refractory celiac disease progression from celiac disease.
Hrdlickova B; Mulder CJ; Malamut G; Meresse B; Platteel M; Kamatani Y; Ricaño-Ponce I; van Wanrooij RLJ; Zorro MM; Jan Bonder M; Gutierrez-Achury J; Cellier C; Zhernakova A; Nijeboer P; Galan P; Withoff S; Lathrop M; Bouma G; Xavier RJ; Jabri B; Bensussan NC; Wijmenga C; Kumar V
Eur J Gastroenterol Hepatol; 2018 Aug; 30(8):828-837. PubMed ID: 29787419
[TBL] [Abstract][Full Text] [Related]
12. AGA Clinical Practice Update on Management of Refractory Celiac Disease: Expert Review.
Green PHR; Paski S; Ko CW; Rubio-Tapia A
Gastroenterology; 2022 Nov; 163(5):1461-1469. PubMed ID: 36137844
[TBL] [Abstract][Full Text] [Related]
13. Mucosal intraepithelial T-lymphocytes in refractory celiac disease: a neoplastic population with a variable CD8 phenotype.
de Mascarel A; Belleannée G; Stanislas S; Merlio C; Parrens M; Laharie D; Dubus P; Merlio JP
Am J Surg Pathol; 2008 May; 32(5):744-51. PubMed ID: 18360280
[TBL] [Abstract][Full Text] [Related]
14. Refractory celiac disease: an unusual disease in a Chinese patient.
Lok KH; Yeung HC; Li KF; Li KK; Szeto ML
J Dig Dis; 2008 Nov; 9(4):238-40. PubMed ID: 18959597
[TBL] [Abstract][Full Text] [Related]
15. Is refractory celiac disease more severe in old Europe?
Malamut G; Cellier C
Am J Gastroenterol; 2011 May; 106(5):929-32. PubMed ID: 21540899
[TBL] [Abstract][Full Text] [Related]
16. Classification and management of refractory coeliac disease.
Rubio-Tapia A; Murray JA
Gut; 2010 Apr; 59(4):547-57. PubMed ID: 20332526
[TBL] [Abstract][Full Text] [Related]
17. Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.
Hussein S; Gindin T; Lagana SM; Arguelles-Grande C; Krishnareddy S; Alobeid B; Lewis SK; Mansukhani MM; Green PHR; Bhagat G
J Clin Pathol; 2018 Sep; 71(9):825-831. PubMed ID: 29703761
[TBL] [Abstract][Full Text] [Related]
18. The Intracellular Intensity of CD3 on Aberrant Intraepithelial Lymphocytes Is a Prognostic Factor of the Progression to Overt Lymphoma in Refractory Celiac Disease Type II (Pre-Enteropathy-Associated T Cell Lymphoma).
García-Hoz C; Crespo L; Lopez N; De Andrés A; Ríos León R; Santón A; Garriga M; Butz E; León F; Roy Ariño G
Dig Dis; 2020; 38(6):490-499. PubMed ID: 32015237
[TBL] [Abstract][Full Text] [Related]
19. NKp46 is a diagnostic biomarker and may be a therapeutic target in gastrointestinal T-cell lymphoproliferative diseases: a CELAC study.
Cheminant M; Bruneau J; Malamut G; Sibon D; Guegan N; van Gils T; Cording S; Trinquand A; Verkarre V; Lhermitte L; Brousse N; Jannot AS; Khater S; Frenzel L; Delarue R; Suarez F; Marçais A; Mulder CJ; Macintyre E; Asnafi V; Pouyet L; Bonnafous C; Lhospice F; Molina TJ; Meresse B; Cellier C; Cerf-Bensussan N; Hermine O;
Gut; 2019 Aug; 68(8):1396-1405. PubMed ID: 30448772
[TBL] [Abstract][Full Text] [Related]
20. Increased IgA glycoprotein-2 specific antibody titres in refractory celiac disease.
Gross S; Bakker SF; van Bodegraven AA; van Hoogstraten IM; Gelderman KA; Bouma G; Mulder CJ; von Blomberg BM; Bontkes HJ
J Gastrointestin Liver Dis; 2014 Jun; 23(2):127-33. PubMed ID: 24949603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
